Pioglitazone and thyroid cancer risk in Taiwanese patients with type 2 diabetes 台湾2 型糖尿病患者使用吡格列酮与甲状腺癌风险.

CH Tseng - Journal of Diabetes, 2014 - search.ebscohost.com
The article presents a research that investigates the thyroid and pioglitazone risks of type
two diabetic Taiwanese patients. Researchers studied the database of patients diagnosed …

[引用][C] Pioglitazone and thyroid cancer risk in Taiwanese patients with type 2 diabetes

CH Tseng - 2014 - ir.nhri.org.tw
國家衛生研究院NHRI:Item 3990099045/7926 English | 正體中文 | 简体中文 | Items with full
text/Total items : 11773/12546 (94%) Visitors : 330165 Online Users : 18 RC Version 6.0 © …

[引用][C] Pioglitazone and thyroid cancer risk in Taiwanese patients with type 2 diabetes 2.

CH Tseng - Journal of Diabetes, 2014 - europepmc.org
Pioglitazone and thyroid cancer risk in Taiwanese patients with type 2 diabetes 2. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

[引用][C] Pioglitazone and thyroid cancer risk in Taiwanese patients with type 2 diabetes

CH Tseng - 2014 - 211.76.174.198
國家衛生研究院NHRI:Item 3990099045/7926 English | 正體中文 | 简体中文 | Items with full
text/Total items : 11824/12597 (94%) Visitors : 340722 Online Users : 50 RC Version 6.0 © …

Pioglitazone and thyroid cancer risk in Taiwanese patients with type 2 diabetes 2

CH Tseng - Journal of diabetes, 2014 - pubmed.ncbi.nlm.nih.gov
Pioglitazone and thyroid cancer risk in Taiwanese patients with type 2 diabetes 2 Pioglitazone
and thyroid cancer risk in Taiwanese patients with type 2 diabetes 2 J Diabetes. 2014 …

[引用][C] Pioglitazone and thyroid cancer risk in T aiwanese patients with type 2 diabetes 台湾2 型糖尿病患者使用吡格列酮与甲状腺癌风险

CH Tseng - Journal of Diabetes, 2014 - Wiley Online Library
Materials and methods An ethic review board of the National Health Research Institutes
approved this study (approval number 99274).